Contributed by Lauren Weiner, Ksana Health Director of Clinical Science. On June 21, 2023, Ksana Health recently attended the 2023 Society for Digital Mental Health Conference. The event highlighted the role of...
Continue readingKsana Health is jazzed to be selected to join the Beyond Language Studio, a collaboration between Sorenson and Newlab supporting deep-tech startups building high-impact, innovative products, and services through real-world pilot projects. The...
Continue readingFor Ksana Health, 2022 was a year of perseverance, learning and optimization. We are grateful to all the partners, collaborators and supporters who made the year what it was. The video below...
Continue readingWe are glad to share this recent publication of the Transitions in Adolescent Girls (TAG) Study (McNeilly, 2023), a longitudinal study examining the extent to which daily mood is associated with digital...
Continue readingKsana Health completed its first third-party assessment for security and privacy controls, receiving unqualified approval attesting to the strength of our controls and compliance with best practices and statutory requirements, including: AICPA,...
Continue readingPalo Santo, a venture fund focused on psychedelic therapeutics and a Ksana Health investor, took a survey of the perspectives of a number of thought leaders in the psychedelics space in light...
Continue readingRecently Ksana Health was highlighted in an interview with Matt Dugan, Head of Business Innovation Garage at Global IT, Novo Nordisk. Kim Stensdal of The Danish IT Society conducted this interview on...
Continue readingAt Ksana Health, we provide our continuous behavior measurement platform (CBHM), Effortless Assessment of Risk States (EARS), to clinical researchers. This platform has given them richer insight into the passive behavior of...
Continue readingTrip Planning: Psychedelics and Digital Therapies March 16, 2022 · 11:30 a.m. Ksana Health’s CEO and Co-Founder Dr. Nick Allen is participating in a panel discussion on recent innovations in mental health...
Continue readingPilot Program Leverages Continuous Objective Measurement to Identify and Address Aspects of Behavior Related to Improved Health Outcomes Ksana Health has been selected by Novo Nordisk’s Global Prevention Accelerator to apply continuous...
Continue reading